Background Obstructive sleep apnea is associated with hypertension, inflammation, and
increased cardiovascular risk. Continuous positive airway pressure (CPAP) reduces blood …

Background Obstructive sleep apnea is associated with an increased risk of cardiovascular
events; whether treatment with continuous positive airway pressure (CPAP) prevents major …

Background Previous, largely uncontrolled studies demonstrated the substantial effects of
continuous positive airway pressure ventilation (CPAP) on a variety of physiologic and …

Background A strong association between obstructive sleep apnea (OSA) and the risk for
cardiovascular and cerebrovascular diseases has been reported. Continuous positive …

Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients
with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with …

Obstructive sleep apnea (OSA) commonly occurs in patients with increased cardiovascular
(CV) risk, and continuous positive airway pressure (CPAP) is the preferred therapy for these …

Background Studies have reported inconsistent findings regarding the association between
obstructive sleep apnea (OSA) and future risks of cardiovascular and all-cause mortality. We …

Obstructive sleep apnea (OSA) is associated with cardiovascular risk factors, cardiovascular
diseases, and increased mortality. Epidemiological studies have established these …

Background It remains uncertain whether continuous positive airway pressure (CPAP)
therapy would significantly impact hard clinical outcomes in patients with obstructive sleep …

Background Continuous positive airway pressure (CPAP) for symptomatic obstructive sleep
apnoea (OSA) improves sleepiness and reduces vascular risk, but such treatment for the …